We could not find any results for:
Make sure your spelling is correct or try broadening your search.
Name | Symbol | Market | Type |
---|---|---|---|
Burning Rock Biotech Ltd | LSE:BNR | London | Depository Receipt |
Price Change | % Change | Price | Bid Price | Offer Price | High Price | Low Price | Open Price | Traded | Last Trade | |
---|---|---|---|---|---|---|---|---|---|---|
0.00 | 0.00% | 0.35 | 0 | 01:00:00 |
TIDMBNR
RNS Number : 6386R
Blenheim Natural Resources PLC
25 September 2017
25 September 2017
Blenheim Natural Resources Plc
("Blenheim" or the "Company")
Placing to Raise GBP900,000
The Company is pleased to announce that it has raised a total of GBP900,000 before expenses through a placing ("Placing") of 200,000,000 ordinary shares of 0.1 pence each in the capital of the Company ("Ordinary Shares") at a price of 0.45 pence per Ordinary Share (the "Placing Price"). The Company will use the funds raised by the Placing to make further investments in accordance with its investing policy.
Application will be made for the admission of the new Ordinary Shares to trading on AIM ("Admission"), with Admission expected to take place on or around 28 September 2017.
Total Voting Rights
Following Admission, the Company's issued share capital will comprise 926,174,497 Ordinary Shares, each with voting rights. The above figure of 926,174,497 Ordinary Shares may be used by shareholders in the Company as the denominator for the calculations by which they will determine if they are required to notify their interest in, or a change in their interest in, the share capital of the Company under the Disclosure and Transparency Rules.
In connection with the Placing, the Company has also agreed to issue 10,000,000 warrants over Ordinary Shares to Novum Securities Ltd ("Warrants"). Each Warrant entitles the holder to subscribe for one Ordinary Share at an exercise price of 0.65 pence per Ordinary Share and will be exercisable at any time for a period of two years from the date of issue of Ordinary Shares pursuant to the Placing.
Blenheim's Chairman, Chris Ells, commented: "Funds raised from this Placing will significantly strengthen the Company's Balance Sheet and thereby provide Blenheim with further firepower to actively pursue its pipeline of investment opportunities with particular emphasis on the lithium and new energy space in Africa."
The information communicated in this announcement contains inside information for the purposes of Article 7 of the Market Abuse Regulation (EU) No. 596/2014.
For further information please contact:
Chris Ells Blenheim Natural Resources Plc +44(0)1622 844601
Neil Baldwin/Mark Brady SPARK Advisory Partners Limited +44(0)203 368 3554
Nick Emerson SI Capital Ltd +44(0)1483 413500 Lucy Williams / Duncan Vasey Peterhouse Corporate Finance Limited +44(0)207 469 0930 Nick Bealer Cornhill Capital Limited +44(0)207 710 9610
This information is provided by RNS
The company news service from the London Stock Exchange
END
IOEKZLFLDKFXBBQ
(END) Dow Jones Newswires
September 25, 2017 02:01 ET (06:01 GMT)
1 Year Burning Rock Biotech Chart |
1 Month Burning Rock Biotech Chart |
It looks like you are not logged in. Click the button below to log in and keep track of your recent history.
Support: +44 (0) 203 8794 460 | support@advfn.com
By accessing the services available at ADVFN you are agreeing to be bound by ADVFN's Terms & Conditions